腫瘤能量代謝重排與轉(zhuǎn)移關(guān)系

1、腫瘤能量代謝重排（reprograming）與轉(zhuǎn)移2。腫瘤細(xì)胞即使在供氧充足的情況下，葡萄糖依舊向乳酸轉(zhuǎn)換，這種代(aerobicglycolysis“Warburg(Warburgeffect)協(xié)調(diào)，產(chǎn)生代謝共生 (metabolism of symbiosis)。腫瘤組織存在著異常復(fù)雜的微環(huán)境重編程 (metabolic reprogramming)。腫瘤的能量代謝重編程是指腫瘤細(xì)胞中 ATP 的主要生成方式由葡萄糖的有氧氧化偶聯(lián)18F-脫氧葡萄糖-PET/CT3。能量代謝是有機(jī)體在物質(zhì)代謝過(guò)程中能量的產(chǎn)先鋒理論-Warburg 效應(yīng) 4。雖然糖酵解產(chǎn)能效率低，但對(duì)于快速增殖的腫瘤細(xì)胞而言

2、這卻ATP，還能為新細(xì)胞的構(gòu)筑提供多種生物大分子，從1.ATP6。reprogramming8。Venkatanarayanp63p73N37IAPPp539。他們I/IIp53快速退化，這為日后靶向 p53 缺失的腫瘤的治療提供了參考。Jiang L 等人發(fā)現(xiàn), TGF1EMT Snail1（FASNTGF1EMT10（PGC-1）入性乳腺癌的臨床分析發(fā)現(xiàn)，PGC-1PGC-111。此外，被認(rèn)為來(lái)源于間充質(zhì)干細(xì)12-14。1B1617。在以雙室模型代謝方式為主的腫瘤組織中，基質(zhì)細(xì)胞發(fā)生過(guò)4其他氨基酸等支持腫瘤細(xì)胞的生長(zhǎng)。而癌細(xì)胞攝取代謝產(chǎn)物的轉(zhuǎn)運(yùn)體單羧酸轉(zhuǎn)運(yùn)蛋白 1 表轉(zhuǎn)運(yùn)蛋白 4 進(jìn)行自噬

3、和糖酵解為主的分解代謝，另一部分腫瘤細(xì)胞主要表達(dá)單羧酸轉(zhuǎn)運(yùn)蛋1ATPmicroRNA WaburgWarbugWarburg過(guò)調(diào)整能量代謝以適應(yīng)其生物合成的需要 20（oxidativephosphorylation，OXPHOS）作為生物能量來(lái)源時(shí)，腫瘤細(xì)胞卻更多地依賴于糖酵解， 這種轉(zhuǎn)變稱為“ Warburg 效應(yīng)”。能量代謝重組（reprogrammingofenergy 些基因的調(diào)控， 也依賴于特定的物質(zhì)（ 如谷氨酰胺等 。此 外， 缺氧誘導(dǎo)因子（hypoxia-induciblefactor，HIF）21。腫瘤細(xì)胞還可通過(guò)其他途徑，如逆向“ Warburg 效應(yīng)”和截?cái)嗟娜人嵫h(huán)（

4、truncated tricarboxylic acid cycle，來(lái)重組腫瘤的能量代謝。DangCV.Linksbetweenmetabolismandcancer. Genes&Development2012;26(9): NordsmarkM,BentzenSM,OvergaardJ.Measurementofhumantumouroxygenation statusbyapolarographicneedleelectrode.Ananalysisofinter-andintratumour heterogeneity. Acta Oncologica 1994; 33(4): 38

5、3-9.LuY,YiY,LiuP,etal.Commonhumancancergenesdiscoveredbyintegrated gene-expression analysis. Plos One 2007; 2(11): e1149.WarburgO.OntheOriginofCancerCell.Science(NewYork,NY)1956;123(3191): DouglasH,WeinbergRA.Hallmarksofcancer:thenextgeneration.Cell2011; 144(5): 646.SebastianC.Trackingdowntheorigino

6、fcancer:metabolicreprogrammingasa driverofstemnessandtumorigenesis.CriticalReviewsinOncogenesis2014;19(5): metabolic reprogramming fuels cellgrowthand proliferation. CellMetabolism 2008; 7(1): 11-20.CellMetabolism2011;14(4):VenkatanarayanA,RauljiP,NortonW,etal.IAPP-drivenmetabolicreprogramming Jiang

7、L,XiaoL,SugiuraH,etal.MetabolicreprogrammingduringTGF1-induced epithelial-to-mesenchymal transition. Oncogene 2015; 34(30): 3908.Lebleu VS, OConnell JT, Gonzalez Herrera KN, et al. PGC-1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nature Cel

8、l Biology 2014; 16(10): 992.VeyratM,DurandS,ClasseM,etal.Stimulationofthetoll-likereceptor3 promotesmetabolicreprogramminginheadandneckcarcinomacells. Oncotarget2016; 7(50): 82580.PenkertJ,RippergerT,SchieckM,SchlegelbergerB,SteinemannD,IlligT.On breast cancer. Oncotarget 2016; 7(41): 67626-49.Curry

9、JM,TulucM,WhitakermenezesD,etal.Cancermetabolism,stemnessand tumorrecurrence:MCT1andMCT4arefunctionalbiomarkersofmetabolicsymbiosis in head and neck cancer. Cell Cycle 2013; 12(9): 1371.KimS,KimdH,JungWH,KooJS.Metabolicphenotypesintriple-negativebreast cancer. Tumour Biol 2013; 34(3): 1699-712.Whita

10、ker-Menezes D, Martinez-Outschoorn UE, Lin Z, et al. Evidence for a stromal-epithelial lactate shuttle in human tumors. Cell Cycle 2011; 10(11): 1772-83.selectivelykillshypoxictumorcellsinmice.JournalofClinicalInvestigation 2008; 118(12): 3930.Zheng J. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncology Letters 2012; 4(6): 1151-7.metabolismi